Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 11,515 | 12,411 | 12,295 | 12,042 | 10,178 |
| Cost of Goods | 4,145 | 4,505 | 4,393 | 4,236 | 3,867 |
| Gross Profit | 7,370 | 7,906 | 7,902 | 7,806 | 6,311 |
| Operating Expenses | 5,686 | 6,350 | 5,994 | 5,410 | 6,064 |
| Operating Income | 1,829 | 2,061 | 2,301 | 2,632 | 1,114 |
| Interest Expense | 0 | 15 | 0 | 0 | 19 |
| Other Income | -57 | -189 | -539 | -117 | -279 |
| Pre-tax Income | 1,772 | 1,857 | 1,762 | 2,515 | 816 |
| Income Tax | 18 | -8 | 4 | 4 | 4 |
| Net Income Continuous | 1,754 | 1,865 | 1,758 | 2,511 | 812 |
| Net Income Discontinuous | -107 | 16 | -82 | -74 | -104 |
| Net Income | $1,647 | $1,881 | $1,676 | $2,437 | $708 |
| EPS Basic Total Ops | 0.37 | 0.32 | 0.38 | 0.56 | 0.16 |
| EPS Basic Continuous Ops | 0.40 | 0.32 | 0.40 | 0.57 | 0.19 |
| EPS Basic Discontinuous Ops | -0.03 | N/A | -0.02 | -0.02 | -0.02 |
| EPS Diluted Total Ops | 0.06 | -0.69 | 0.38 | 0.55 | 0.16 |
| EPS Diluted Continuous Ops | 0.06 | -0.75 | 0.40 | 0.57 | 0.19 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.04 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.06 | N/A | 0.31 | 0.48 | N/A |
| EBITDA(a) | $2,030 | $2,272 | $2,490 | $2,820 | $1,274 |